Summary
Performing gene hunting in fetal Down Syndrome (DS) brain, we found a downregulated sequence with 100% homology to the basic — helix — loop — helix transcription factor (TF) scleraxis (Scl).
It was the aim of the study to evaluate Scl — mRNA steady state levels in adult DS brain with Alzheimer’s disease (AD) neuropathological changes, brain of patients with AD, and controls in order to find out whether Scl — downregulation is linked to DS per se or simply to neurodegeneration, common to both disorders.
Determination of Scl — mRNA steady state levels was carried out by a blotting method in frontal, parietal, temporal, occipital lobe and cerebellum.
We found significantly decreased Scl — transcripts in brain of DS and AD, both, when normalized versus the house-keeping gene beta actin or total RNA.
We demonstrate the significant decrease of Scl — mRNA steady state levels in the pathogenesis of DS and AD suggesting a tentative role for this transcription factor in the development of the neurodegenerative processes known to occur in both disorders. More specifically, the biological meaning of the downregulation of Scl may be the involvement in the pathogenesis of impaired neuronal plasticity and wiring observed in DS and AD, phenomena regulated by the concerted action of the many transcription factors expressed in human brain.
K. Y. is sponsored by a fellowship of the International Society for Amino Acid Research
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde BO, Moreno RF, Kerlavage AR, McCombie WR, Venter JC (1991) Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252: 1651–1656
Adams MD, Dubnick M, Kerlavage AR, Moreno R, Kelley JM, Utterback RT, Nagle JW, Fields C, Venter JC (1992) Sequence identification of 2,375 human brain genes. Nature 355: 632–634
Arenander AT, De Vellis J (1994) Development of the nervous system. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic neurochemistry, 5th edn. Raven Press, New York, pp 573–606
Burger PC, Vogel FS (1973) The development of pathologic changes of Alzheimer’s disease and senile dementia in patients with Down’s syndrome. Am J Pathol 73: 457–476
Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779
Cserjesi P, Brown D, Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, Jenkins NA, Olson EN (1995) Scleraxis: a basic helix-loop-helix protgein that prefigures skeletal formation during mouse embryogenesis. Development 121: 1099–1110
Epstein CJ (1992) Down Syndrome (Trisomy 21) In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 749–794
Fang-Kircher S, Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G (1999) Increased steady state mRNA levels of DNA repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down Syndrome. Life Sci (in press)
Hardmeier R, Hoeger H, Fang-Kircher S, Khoshsorur A, Lubec G (1997) Transcription and activity of superoxide dismutase, catalase and glutathione peroxidase following irradiation in radiation resistant and radiation sensitive mice Proc. Natl Acad Sci (USA) 94: 7572–7576
He X, Rosenfeld MG (1991) Mechanisms of complex transcriptional regulation: implications for brain development. Neuron 7: 183–196
Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase — 3 family protease. Science 277: 373–376
Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whithouse PJ, Taniguchi T (1998) Alteration of proteins regulating apoptosis, bcl-2, bcll-x, bax, bak, bad, ICH-1 and CPP32 in Alzheimer’s disease. Brain Res 780: 260–269
Kola I, Christiano F, de Haan JB, Thomas R, Sumarsono S, Corrick CM, Tymms M (1995) Genes, embryogenesis and Down Syndrome. In: Moeloek FA, Affandi B, Trounson AO (eds) Advances in human reproduction. Casterton-Parthenon, NY, pp 309–320
Labudova O, Lubec G (1998) cAMP upregulates the transposable element mys-1: a possible link between signaling and mobile DNA. Life Sci 62: 431–437
Labudova O, Fang-Kircher S, Cairns N, Lubec G (1998) Upregulation of vasopressin in brain of patients with Down Syndrome. Brain Res 806: 55–59
Labudova O, Krapfenbauer K, Moenkemann H, Rink H, Kitzmueller E, Cairns N, Lubec G (1998) Decreased transcription factor junD in brain of patients with Down Syndrome. Neurosci Lett 252: 159–162
Liu Y, Cserjesi P, Nifuji A, Olson EN, Noda M (1996) Sclerotome-related helix-loop-helix type transcription factor (scleraxis) mRNA is expressed in osteoblasts and its level is enhanced by type-beta transforming growth factor. J Endocrinol 151: 491–499
Liu Y, Nifuji A, Tamura M, Wozney JM, Olson EN, Noda M (1997) Scleraxis messenger ribonucleic acid is expressed in C2C12 myoblasts and its level is down-regulated by bone morphogenetic protein’ 2 (BMP2). J Cell Biochem 67: 66–74
Liu Y, Watanabe H, Nifuji A, Yamada Y, Olson EN, Noda M (1997) Overexpression of a single helix-loop-helix type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem 272: 29880–29885
Ma L, Westbroek A, Jochemsen AG, Weeda G, Bosch A, Bootsma D, Hoeijmakers JHJ, van der Erb AJ (1994) Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation: identification of domains essential for the DNA repair function. Mol Cell Biol 14: 4126–4134
McMaster GK, Carmichael GG (1977) Analysis by single and double stranded nucleic acids on Polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci (USA) 74: 4835–4841
Mirra SS, Heyman A, McKeel D, Sumi S, Crain BJ (1991) The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardisation of the neuropathologi-cal assessment of Alzheimer’s disease. Neurology 41: 479–486
Morris BJ (1997) Neuronal plasticity. In: Davies RW, Morris BJ (eds) Molecular biology of the neuron. Bios Scientifique Publishers, Oxford, pp 323–335
Nagy ZS, Esiri MM (1997) Apoptosis — related protein expression in the hippocampus in Alzheimer’s disease. Neurobiol Aging 18: 565–571
Schaeffer L, Moncollin V, Roy R, Staub A, Mezzina M, Sarasin A, Weeda G, Hoeijmakers JHJ, Egly JM (1994) The ERCC2 / DNA repair protein is associated with the class II BTF2 / TFIIH transcription factor. EMBO J 13: 2388–2392
Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DNA damage in Down Syndrome. Neurosci Lett 235: 137–140
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–511
Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraaten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease. Neurology 38: 359–364
Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupoid SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JHJ, Harris CC (1996) The XPB and XPD DNA helicases are components of the p53 mediated apoptosis pathway. Genes Dev 10: 1219–1232
Warbrick E (1996) Apoptosis: a new twist to the tale? Curr Biol 6: 1057–1059
White BA, Bancroft FC (1982) Cytoplasmic dot hybridization. Simple analysis of mRNA levels in multiple small cell or tissue samples. J Biol Chem 257: 8569–8574
Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 17: 278–282
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this paper
Cite this paper
Yeghiazaryan, K. et al. (1999). Downregulation of the transcription factor scleraxis in brain of patients with Down Syndrome. In: Lubec, G. (eds) The Molecular Biology of Down Syndrome. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6380-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6380-1_21
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83377-3
Online ISBN: 978-3-7091-6380-1
eBook Packages: Springer Book Archive